Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation

• Hlavní autoři: Guru Subramanian Guru Murthy (Autor), Tao Zhang (Autor), Yung-Tsi Bolon (Autor), Stephen Spellman (Autor), Jing Dong (Autor), Paul Auer (Autor), Wael Saber (Autor)
• Médium: Kniha
• Vydáno: BMC, 2024-01-01T00:00:00Z.
• Témata: article
• On-line přístup: Connect to this object online.

Abstract Disease relapse remains a major barrier to success after allogeneic hematopoietic cell transplantation (allo-HCT) in myelodysplastic neoplasms (MDS). While certain high risk genomic alterations are associated with increased risk of relapse, there is a lack of clinically applicable tools to...